Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance.

Genome biology - 30 Aug 2014

Siravegna Giulia, Bardelli Alberto

Abstract excerpt

DNA fragments released from cancer cells into the blood can be used to generate molecular profiles of tumors. Non-invasive 'liquid biopsies' can be used to monitor minimal residual disease and detect the emergence of drug resistance.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cell-Free System
Share to DNA, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Neoplasm

Share to Genotype

Share to Lung Cancer Treatments and Mutations

Share to Neoplasm, Residual

Share to Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 25222559
DOI: 10.1186/s13059-014-0449-4
PMCID: PMC4281953

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotyping cell-free tumor DNA in the blood to detect residual disease and drug resistance.PMID 25222559Read ↗

Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?Semantic proximity Read ↗

Liquid biopsies: genotyping circulating tumor DNA.Semantic proximity Read ↗

Cell-Free DNA in Oncology: Gearing up for Clinic.Semantic proximity Read ↗

Liquid Biopsy: Approaches to Dynamic Genotyping in CancerSemantic proximity Read ↗

A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.Semantic proximity Read ↗

Circulating tumor DNA: current challenges for clinical utility.Semantic proximity Read ↗

Circulating tumor DNA in clinical trials for solid tumors: Challenges and current applicationsSemantic proximity Read ↗

Genomic approaches to cancer and minimal residual disease detection using circulating tumor DNASemantic proximity Read ↗

Toward liquid biopsies in cancer treatment: application of circulating tumor DNASemantic proximity Read ↗

Circulating-tumor DNA as an early detection and diagnostic tool.Semantic proximity Read ↗

Circulating Cell-Free DNA—Diagnostic and Prognostic Applications in Personalized Cancer TherapySemantic proximity Read ↗

Circulating cell-free DNA for non-invasive cancer managementSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.